U.S. IT Stock News

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...

Kodiak Sciences recently reported that its Phase III GLOW2 trial of Zenkuda for diabetic retinopathy met primary and key secondary endpoints with strong efficacy, and the company is also advancing multiple late-stage ophthalmology programs while maintaining a solid, debt-free balance sheet. This combination of positive late-stage data and an accelerated regulatory submission plan highlights how central Zenkuda has become to Kodiak’s overall pipeline story. Next, we’ll examine how Zenkuda’s...

In late April 2026, Weyerhaeuser reported Q1 results that topped expectations, with US$1.73 billion in net sales, US$77 million in adjusted net earnings, and completion of a US$192 million divestiture of 108,000 acres of non-core Virginia timberlands. Beyond the quarterly beat, the sale of lower-priority timberlands and progress in higher-margin Wood Products and Strategic Land Solutions highlight how Weyerhaeuser is reshaping its portfolio toward higher-return uses of its asset base. Next,...

In recent developments, Energy Vault Holdings reported very large year-over-year revenue growth for fiscal 2025, driven by project execution in Australia and the U.S., the ramp-up of its Asset Vault portfolio, and US$450 million of new strategic financing, while shareholders reelected three Class II directors and ratified BDO USA, P.C. as auditor for the fiscal year ending December 31, 2026. Together, the rapid expansion of contracted capacity to 540 megawatts and the move into AI-focused...

Forgent Power Solutions, Inc. recently completed a follow-on equity offering of approximately US$1.99 billion, issuing 42,280,000 Class A common shares at US$47 each, slightly below the reference price. This capital raise follows the company’s move to reprice its senior credit facilities and target lower interest costs, highlighting an active approach to reshaping its capital structure. We’ll now examine how this large equity raise, alongside the repriced credit facilities, may influence...

Arcosa has completed the US$450 million sale of its barge business and, in its latest reported quarter, delivered 10% adjusted EBITDA growth with record results in utility structures while sharpening its focus on Construction Products and Engineered Structures. The company has also raised its full-year 2026 guidance for both revenue and adjusted EBITDA growth, highlighting how the streamlined portfolio and stronger cash generation are shaping its post-divestiture direction. We’ll now examine...

UBS recently downgraded EHang Holdings (EH) after citing slower commercialization of its eVTOL aircraft, increased dependence on government approvals, reduced revenue and shipment projections, and a delayed path to breakeven. See our latest analysis for EHang Holdings. The downgrade has come on top of already weak momentum. The stock is down 32.9% on a 90 day share price return, and the 1 year total shareholder return has declined 51.5%. This signals fading enthusiasm as commercialization...

With inflation readings, interest-rate expectations and energy prices all pulling investors in different directions, it can help to focus on clear, structural trends backed by real-world use cases. Artificial intelligence in healthcare fits that bill, with applications in diagnostics, personalised treatment, hospital efficiency and drug discovery already reshaping how care is delivered. Our Transformative AI Healthcare Stocks screener is designed to filter for companies directly exposed to...

OceanFirst Financial (NasdaqGS:OCFC) has completed its merger with Flushing Financial, creating a larger combined bank. As part of the transaction, John R. Buran has been appointed non executive chairman of the expanded board. Warburg Pincus has invested $225 million through a private placement, adding fresh capital to the company. For investors tracking regional banks, OceanFirst Financial now looks very different from just a few months ago. The stock last closed at $18.14, with a return...

Quantinuum stock in focus Quantinuum (QNT) has drawn investor attention after its recent share price move, with the stock closing at US$56.26 and showing a day return that suggests short term trading interest around this quantum computing specialist. See our latest analysis for Quantinuum. That single day share price return of down 6.82% and year-to-date share price return matching the same decline signal that recent momentum has cooled, even as interest in quantum computing remains firmly in...

In early June 2026, Antero Resources was highlighted for its strong growth profile and leading U.S. natural gas liquids and LNG exposure amid geopolitical tensions that have tightened global energy markets, even as recent insider share sales created some concerns. Analysts and hedge funds have recently emphasized that Antero’s export-oriented NGL and LNG footprint could benefit from current Middle East supply disruptions, reinforcing its role as a key U.S. supplier in a reshaped global...

On May 27, 2026, Microvast Holdings, Inc. reported that Chief Accounting Officer Eric N. Garcia left the company, shortly before law firm Halper Sadeh LLC began investigating whether certain officers and directors breached fiduciary duties to shareholders. This combination of an accounting leadership change and a shareholder-focused legal review raises fresh questions about Microvast’s governance, oversight, and internal controls. Next, we’ll examine how the investigation into potential...

Dividend affirmation against a backdrop of heavy short interest Medical Properties Trust (MPT) affirmed its regular quarterly dividend at US$0.09 per share, even as the stock carries the highest reported short interest among REITs and continues to face questions about its balance sheet. See our latest analysis for Medical Properties Trust. At a share price of US$4.98, Medical Properties Trust has posted a 1 year total shareholder return of 17.71%, although its 5 year total shareholder return...

In recent weeks, Laser Photonics Corporation reported that its Laser Shield Anti-Drone system advanced into U.S. Department of War evaluation under the MEIA Vulcan program, while also securing a US$13.20 million follow-on order from the US Navy and a US$250,000 custom medical laser drilling order from Johnson & Johnson. Taken together, these defense and medical wins point to growing third-party validation of Laser Photonics’ laser platforms across mission-critical and high-specification...

In late May 2026, Ropes & Gray and Arkwright Consulting each announced they had selected Intapp’s DealCloud platform, with Ropes & Gray also adopting the new Celeste agentic AI to connect growth, compliance, and profitability workflows. These wins highlight growing real‑world adoption of Intapp’s cloud and AI stack across legal and consulting firms, directly tying its technology roadmap to mission‑critical client workflows. Next, we’ll examine how Celeste’s launch as an agentic AI layer for...

Merlin (MRLN) has completed the Critical Design Review for its C-130J autonomy program with U.S. Special Operations Command, marking a key milestone that moves the AI flight system into aircraft integration and formal testing. See our latest analysis for Merlin. The C-130J design milestone has coincided with a sharp shift in sentiment, with Merlin’s 1-day share price return of 19.78% and 7-day share price return of 6.83% contrasting with a 90-day share price return that is down 17.94% and a...

In early June 2026, Comstock Inc. filed a shelf registration to offer up to US$100.875 million of common shares, covering 7,500,000 shares in an ESOP-related structure. This filing signals potential future capital raising and broader employee ownership, factors that could affect Comstock’s capital structure, dilution profile, and governance priorities. Next, we’ll examine how this potential US$100.875 million shelf registration shapes Comstock’s investment narrative around growth funding and...

We wouldn't blame JFrog Ltd. ( NASDAQ:FROG ) shareholders if they were a little worried about the fact that Shlomi...

UroGen Pharma (URGN) has come into focus after announcing a settlement and license agreement with Teva Pharmaceuticals covering Jelmyto. The deal clarifies future generic entry timing and removes ongoing patent litigation risk around this cancer treatment. See our latest analysis for UroGen Pharma. Recent news around Jelmyto has come as the stock cools slightly in the very short term, with the 30 day share price return down 8.67% and the 7 day share price return down 4.55%. This has occurred...

We wouldn't blame NovoCure Limited ( NASDAQ:NVCR ) shareholders if they were a little worried about the fact that Frank...

Earlier this week, Solidion Technology Inc. announced patented breakthroughs in lithium metal and extreme-climate battery platforms tailored for satellites, Low Earth Orbit AI data centers, crewed spacecraft, and future lunar infrastructure, underpinned by more than 385 patents. A distinctive aspect of these announcements is Solidion’s focus on graphene-enabled, ultra-wide-temperature batteries and domestic graphite production, directly addressing both harsh space conditions and U.S...

We'd be surprised if IRADIMED CORPORATION ( NASDAQ:IRMD ) shareholders haven't noticed that the Independent Director...

Investors may wish to note that the CEO, President & Director of Pulmonx Corporation , Glendon French, recently netted...

Some Lincoln National Corporation ( NYSE:LNC ) shareholders may be a little concerned to see that the Executive VP and...